Cargando…

Hip Morphology in Mucolipidosis Type II

Mucolipidosis type II (MLII) is a rare lysosomal storage disorder caused by defective trafficking of lysosomal enzymes. Severe skeletal manifestations are a hallmark of the disease including hip dysplasia. This study aims to describe hip morphology and the natural course of hip pathologies in MLII b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ammer, Luise Sophie, Oussoren, Esmeralda, Muschol, Nicole Maria, Pohl, Sandra, Rubio-Gozalbo, Maria Estela, Santer, René, Stuecker, Ralf, Vettorazzi, Eik, Breyer, Sandra Rafaela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141371/ https://www.ncbi.nlm.nih.gov/pubmed/32182687 http://dx.doi.org/10.3390/jcm9030728

Ejemplares similares

Anaesthesia-Relevant Disease Manifestations and Perianaesthetic Complications in Patients with Mucolipidosis—A Retrospective Analysis of 44 Anaesthetic Cases in 12 Patients
por: Ammer, Luise Sophie, et al.
Publicado: (2022)

Is hematopoietic stem cell transplantation a therapeutic option for mucolipidosis type II?
por: Ammer, Luise Sophie, et al.
Publicado: (2021)

Hip pathologies in mucopolysaccharidosis type III
por: Breyer, Sandra Rafaela, et al.
Publicado: (2021)

CNS Manifestations in Mucolipidosis Type II—A Retrospective Analysis of Longitudinal Data on Neurocognitive Development and Neuroimaging in Eleven Patients
por: Ammer, Luise Sophie, et al.
Publicado: (2023)

Hip Dysplasia in Mucopolysaccharidosis Type IVA (Morquio A Syndrome) Treated by Proximal Femoral Valgization Osteotomy: A Case Report
por: Berger-Groch, Josephine, et al.
Publicado: (2018)

Anterior distal femoral hemiepiphysiodesis can reduce fixed flexion deformity of the knee: a retrospective study of 83 knees
por: Stiel, Norbert, et al.
Publicado: (2018)

Disease Manifestations in Mucopolysaccharidoses and Their Impact on Anaesthesia-Related Complications—A Retrospective Analysis of 99 Patients
por: Ammer, Luise Sophie, et al.
Publicado: (2021)

Growth modulation with a medial malleolar screw for ankle valgus deformity: 79 children with 125 affected ankles followed until correction or physeal closure
por: Rupprecht, Martin, et al.
Publicado: (2015)

Pathogenic variants in GNPTAB and GNPTG encoding distinct subunits of GlcNAc-1-phosphotransferase differentially impact bone resorption in patients with mucolipidosis type II and III
por: Di Lorenzo, Giorgia, et al.
Publicado: (2021)

Sex differences in the morphological failure patterns following hip resurfacing arthroplasty
por: Hinsch, Andrea, et al.
Publicado: (2011)

Decreased bone formation and increased osteoclastogenesis cause bone loss in mucolipidosis II
por: Kollmann, Katrin, et al.
Publicado: (2013)

Mucolipidosis type III, a series of adult patients
por: Oussoren, Esmee, et al.
Publicado: (2018)

Neurologic Abnormalities in Mouse Models of the Lysosomal Storage Disorders Mucolipidosis II and Mucolipidosis III γ
por: Idol, Rachel A., et al.
Publicado: (2014)

Correction: Neurologic Abnormalities in Mouse Models of the Lysosomal Storage Disorders Mucolipidosis II and Mucolipidosis III γ
Publicado: (2014)

Case Report: Mucolipidosis II and III Alpha/Beta Caused by Pathogenic Variants in the GNPTAB Gene (Mucolipidosis)
por: Mao, Shao-Jia, et al.
Publicado: (2022)

Probing pathomechanisms of mucolipidosis II in fish
Publicado: (2012)

The Dictyostelium Model for Mucolipidosis Type IV
por: Allan, Claire Y., et al.
Publicado: (2022)

Orofacial abnormalities in mucopolysaccharidosis and mucolipidosis type II and III: A systematic review
por: de Bode, Chiel J., et al.
Publicado: (2022)

Autophagic dysfunction in mucolipidosis type IV patients
por: Vergarajauregui, Silvia, et al.
Publicado: (2008)

Transgenic inhibition of interleukin-6 trans-signaling does not prevent skeletal pathologies in mucolipidosis type II mice
por: Westermann, Lena Marie, et al.
Publicado: (2021)

Outcome of the modified Dunn procedure in severe chronic or acute on chronic slipped capital femoral epiphysis
por: Ebert, Nicola, et al.
Publicado: (2019)

Mucolipidosis II: first report from Saudi Arabia
por: Alfadhel, Majid, et al.
Publicado: (2013)

Unique molecular signature in mucolipidosis type IV microglia
por: Cougnoux, Antony, et al.
Publicado: (2019)

Diagnosis of Mucopolysaccharidoses and Mucolipidosis by Assaying Multiplex Enzymes and Glycosaminoglycans
por: Arunkumar, Nivethitha, et al.
Publicado: (2021)

Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation
por: Schmidt, Mona, et al.
Publicado: (2016)

The first genetically confirmed Japanese patient with mucolipidosis type IV
por: Saijo, Harumi, et al.
Publicado: (2016)

Cross-sectional Observations on the Natural History of Mucolipidosis Type IV
por: Misko, Albert L., et al.
Publicado: (2022)

New targets for old diseases: lessons from mucolipidosis type II
por: Settembre, Carmine, et al.
Publicado: (2013)

Elevated Bone Turnover in an Infantile Patient with Mucolipidosis II; No Association with Hyperparathyroidism
por: Otomo, Takanobu, et al.
Publicado: (2011)

Mucolipidosis Type II Secondary to GNPTAB Gene Deletion from India
por: Gowda, Vykuntaraju K., et al.
Publicado: (2017)

Humoral immune response in adult Brazilian patients with Mucolipidosis III gamma
por: Sperb-Ludwig, Fernanda, et al.
Publicado: (2019)

Peripheral Inflammatory Cytokine Signature Mirrors Motor Deficits in Mucolipidosis IV
por: Misko, Albert L., et al.
Publicado: (2022)

Imbalanced cellular metabolism compromises cartilage homeostasis and joint function in a mouse model of mucolipidosis type III gamma
por: Westermann, Lena Marie, et al.
Publicado: (2020)

Current and Future Treatments for Classic Galactosemia
por: Delnoy, Britt, et al.
Publicado: (2021)

The mucolipidosis IV Ca(2+) channel TRPML1 (MCOLN1) is regulated by the TOR kinase
por: Onyenwoke, Rob U., et al.
Publicado: (2015)

Biochemical characteristics of a Korean patient with mucolipidosis III (pseudo-Hurler polydystrophy).
por: Song, Junghan, et al.
Publicado: (2003)

Systematic Screens for Proteins That Interact with the Mucolipidosis Type IV Protein TRPML1
por: Spooner, Ellen, et al.
Publicado: (2013)

Impaired myelination and reduced brain ferric iron in the mouse model of mucolipidosis IV
por: Grishchuk, Yulia, et al.
Publicado: (2015)

Pitfalls in the prenatal diagnosis of mucolipidosis II alpha/beta: A case report
por: Alegra, Taciane, et al.
Publicado: (2014)

Characterization of mesenchymal stem cells in mucolipidosis type II (I-cell disease)
por: KÖSE, Sevil, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_be1vj8rehl0h12ic1euj0ac85j